remedi4all.org
👉 More here: remedi4all.org
#REMEDi4ALL #DrugRepurposing
Partners from Syreon Research Institute represented REMEDi4ALL at #ISPOREurope2025 in Glasgow — sharing insights on policy barriers to drug repurposing and patient engagement in early HTA for Losartan in Osteogenesis Imperfecta.
#DrugRepurposing #HTA
Partners from Syreon Research Institute represented REMEDi4ALL at #ISPOREurope2025 in Glasgow — sharing insights on policy barriers to drug repurposing and patient engagement in early HTA for Losartan in Osteogenesis Imperfecta.
#DrugRepurposing #HTA
Join a global community driving the future of drug repurposing.
💡 Cutting-edge science
🤝 Collaboration
⚖️ Policy & access
🔬 Real-world case studies
Connect, share, and shape faster, more affordable treatments.
🔗 https://remedi4all.org/iDR26
Join a global community driving the future of drug repurposing.
💡 Cutting-edge science
🤝 Collaboration
⚖️ Policy & access
🔬 Real-world case studies
Connect, share, and shape faster, more affordable treatments.
🔗 https://remedi4all.org/iDR26
Findings will guide future reforms to improve access to repurposed medicines.
📘More here: https://loom.ly/zCuz-oY
Findings will guide future reforms to improve access to repurposed medicines.
📘More here: https://loom.ly/zCuz-oY
The first REMEDi4ALL Marketplace meeting brought together 30+ participants, including 15 funding organisations.
The Marketplace connects funders and project developers to boost impactful collaborations in drug repurposing.
🔗 https://loom.ly/YBi0wZU
The first REMEDi4ALL Marketplace meeting brought together 30+ participants, including 15 funding organisations.
The Marketplace connects funders and project developers to boost impactful collaborations in drug repurposing.
🔗 https://loom.ly/YBi0wZU
1st story: Sotatercept (Winrevair) — from anaemia to pulmonary hypertension (PAH).
➡️ Download here: https://loom.ly/4Qp4-yg
1st story: Sotatercept (Winrevair) — from anaemia to pulmonary hypertension (PAH).
➡️ Download here: https://loom.ly/4Qp4-yg
With Beacon for Rare Diseases, LifeArc & King’s College London, discover how robust IP planning can accelerate your drug repurposing project.
🔗 https://loom.ly/bG6rhso
With Beacon for Rare Diseases, LifeArc & King’s College London, discover how robust IP planning can accelerate your drug repurposing project.
🔗 https://loom.ly/bG6rhso
Relive the best moments from Amsterdam, where 300+ participants & 60+ experts came together to explore how AI, innovative trials & collaboration can transform #DrugRepurposing.
➡️ Watch the recap on the Conference hub: https://remedi4all.org/idr25-conference/
Relive the best moments from Amsterdam, where 300+ participants & 60+ experts came together to explore how AI, innovative trials & collaboration can transform #DrugRepurposing.
➡️ Watch the recap on the Conference hub: https://remedi4all.org/idr25-conference/
Join the leading international conference on drug repurposing to explore the next chapter in patient-centred innovation from rare diseases and AI to policy and funding.
Early Bird tickets available now ➡️ https://remedi4all.org/iDR26
Join the leading international conference on drug repurposing to explore the next chapter in patient-centred innovation from rare diseases and AI to policy and funding.
Early Bird tickets available now ➡️ https://remedi4all.org/iDR26
🗓️ 21 Nov | 14:00–15:30 CET
Navigating the complex IP landscape in #DrugRepurposing? Join REMEDi4ALL with:
➡️ Madhu Madhusudhan & Svetlana Gracheva (LifeArc)
➡️ John Liddicoat (King’s College London)
➡️ Beacon for Rare Diseases
🔗: https://loom.ly/bG6rhso
🗓️ 21 Nov | 14:00–15:30 CET
Navigating the complex IP landscape in #DrugRepurposing? Join REMEDi4ALL with:
➡️ Madhu Madhusudhan & Svetlana Gracheva (LifeArc)
➡️ John Liddicoat (King’s College London)
➡️ Beacon for Rare Diseases
🔗: https://loom.ly/bG6rhso
Gathier Bouche from The Anticancer Fund joined a session on EU drug repurposing initiatives, where he showcased how REMEDi4ALL is advancing the repurposing of medicines.
🔗 https://irdirc.org/
Gathier Bouche from The Anticancer Fund joined a session on EU drug repurposing initiatives, where he showcased how REMEDi4ALL is advancing the repurposing of medicines.
🔗 https://irdirc.org/
Barbara Goodman (Cures Within Reach) & Hans Platteeuw (Galenicap) shared seven #DrugRepurposing projects that reached patients plus key lessons learned.
The Funders Network unites funders to boost collaboration & impact.
🔗More: https://loom.ly/ZTiu4mQ
Barbara Goodman (Cures Within Reach) & Hans Platteeuw (Galenicap) shared seven #DrugRepurposing projects that reached patients plus key lessons learned.
The Funders Network unites funders to boost collaboration & impact.
🔗More: https://loom.ly/ZTiu4mQ
Read the full event summary and discover who won here➡️https://loom.ly/N6tXCHs
Read the full event summary and discover who won here➡️https://loom.ly/N6tXCHs
As the Hackathon wraps up, participants share how speaking with patients shaped their approach to drug repurposing, showing how patient perspectives drive real-world impact.
🏆 Stay tuned - winner announced soon!
🔗 www.remedi4all.org
As the Hackathon wraps up, participants share how speaking with patients shaped their approach to drug repurposing, showing how patient perspectives drive real-world impact.
🏆 Stay tuned - winner announced soon!
🔗 www.remedi4all.org
Participants are exploring and prioritising drug repurposing candidates for neurodevelopmental disorders, turning data into decisions and shaping target product profiles.
Next: integrating patient perspectives for real-world impact!
Participants are exploring and prioritising drug repurposing candidates for neurodevelopmental disorders, turning data into decisions and shaping target product profiles.
Next: integrating patient perspectives for real-world impact!
📹 Stay tuned to hear directly from our participants and organisers as the week unfolds!
📹 Stay tuned to hear directly from our participants and organisers as the week unfolds!
🗓️ Fri 21 Nov | 14:00-15:30 CET
Join REMEDi4ALL with Beacon for Rare Diseases, LifeArc & King’s College London to explore IP challenges, strategies & practical tips for drug repurposing.
🔗 Register here: https://loom.ly/bG6rhso
🗓️ Fri 21 Nov | 14:00-15:30 CET
Join REMEDi4ALL with Beacon for Rare Diseases, LifeArc & King’s College London to explore IP challenges, strategies & practical tips for drug repurposing.
🔗 Register here: https://loom.ly/bG6rhso
🔗Our interview: https://loom.ly/UV5SWig
🔗Full publication: https://loom.ly/UV5SWig
🔗Our interview: https://loom.ly/UV5SWig
🔗Full publication: https://loom.ly/UV5SWig
Read highlights from our session: patient engagement, training, new tools & collaboration 👉 https://loom.ly/k4uER7w
Read highlights from our session: patient engagement, training, new tools & collaboration 👉 https://loom.ly/k4uER7w
Phospholipidosis, the abnormal build-up of lipids in cells, can distort drug screening results and slow development.
REMEDi4ALL has shared imaging data to improve understanding of this phenomenon and support drug repurposing research.
🔗 https://loom.ly/sKA5Hp4
Phospholipidosis, the abnormal build-up of lipids in cells, can distort drug screening results and slow development.
REMEDi4ALL has shared imaging data to improve understanding of this phenomenon and support drug repurposing research.
🔗 https://loom.ly/sKA5Hp4
Today we’re at Barcelona Biomedical Research Park for REPO4EU's annual conference, joining the community and taking the stage to discuss patient engagement, training, internationalisation and the REMEDi4ALL platform!
Today we’re at Barcelona Biomedical Research Park for REPO4EU's annual conference, joining the community and taking the stage to discuss patient engagement, training, internationalisation and the REMEDi4ALL platform!
The REMEDi4ALL Partnering Portal is now open – creating a pathway for repurposing projects to collaborate with REMEDi4ALL.
If you’re considering a proposal, we encourage you to first connect with the REMEDi4ALL Concierge.
More➡️ https://loom.ly/xs12IxA
The REMEDi4ALL Partnering Portal is now open – creating a pathway for repurposing projects to collaborate with REMEDi4ALL.
If you’re considering a proposal, we encourage you to first connect with the REMEDi4ALL Concierge.
More➡️ https://loom.ly/xs12IxA
Read more here➡️ https://loom.ly/jREI4bU
Read more here➡️ https://loom.ly/jREI4bU
Join REMEDi4ALL’s Digital Academy with King’s College & LifeArc for a webinar on IP Strategies for Repurposing. Learn how to protect discoveries, tackle regulatory issues & move findings closer to patients.
🗓️ 21 Nov, 14:00–15:30 CET
🔗 https://loom.ly/dsFZvjU
Join REMEDi4ALL’s Digital Academy with King’s College & LifeArc for a webinar on IP Strategies for Repurposing. Learn how to protect discoveries, tackle regulatory issues & move findings closer to patients.
🗓️ 21 Nov, 14:00–15:30 CET
🔗 https://loom.ly/dsFZvjU
Our community’s dedication & expertise drive progress in #DrugRepurposing – working together to bring safe & effective drugs to more patients.
➡️ Updates: https://remedi4all.org/
#DrugRepurposing
Our community’s dedication & expertise drive progress in #DrugRepurposing – working together to bring safe & effective drugs to more patients.
➡️ Updates: https://remedi4all.org/
#DrugRepurposing
After 3️⃣ years of collaboration, we’re looking back on our achievements & shaping the next steps to accelerate #PatientCentred medicines repurposing in Europe, & beyond.
➡️ More here: https://remedi4all.org #DrugRepurposing
After 3️⃣ years of collaboration, we’re looking back on our achievements & shaping the next steps to accelerate #PatientCentred medicines repurposing in Europe, & beyond.
➡️ More here: https://remedi4all.org #DrugRepurposing